Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian P Halliday

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
European Journal of Heart Failure|June 18, 2025
Heart failure improvement, remission, and recovery: A European Journal of Heart Failure expert consensus documentJean-Sébastien Hulot, Jozine M Ter Maaten, Antoni Bayes-Genis, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|September 6, 2025
Visually assessed ischaemia on cardiac magnetic resonance, but not quantitative perfusion metrics, predicts symptomatic improvement in coronary artery bypassTamim Akbari, Lukas Mach, Daniel J Hammersley, et al.
Arxiv|June 5, 2025
In Silico Trials for Sex-Specific patient Inclusion Criteria in Cardiac Resynchronization Therapy: Advancing Precision in Heart Failure TreatmentShuang Qian, Devran Ugurlu, Elliot Fairweather, et al.
Journal of the American College of Cardiology|February 18, 2022
Myocardial Fibrosis Predicts Ventricular Arrhythmias and Sudden Death After Cardiac Electronic Device ImplantationFrancisco Leyva, Abbasin Zegard, Osita Okafor, et al.
ESC Heart Failure|March 8, 2022
Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathyBrian P Halliday, Ruth Owen, John Gregson, et al.
Open Heart|January 28, 2022
Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathyDaniel J Hammersley, Rachel J Buchan, Amrit S Lota, et al.
Journal of Cardiac Failure|January 14, 2022
Exposure to Elevated Nitrogen Dioxide Concentrations and Cardiac Remodeling in Patients With Dilated CardiomyopathyDaniela Fecht, Marc Chadeau-Hyam, Ruth Owen, et al.
Frontiers in Cardiovascular Medicine|October 24, 2022
The addition of genetic testing and cardiovascular magnetic resonance to routine clinical data for stratification of etiology in dilated cardiomyopathyRavi J Amin, Deborah Morris-Rosendahl, Mat Edwards, et al.
JACC. Cardiovascular Imaging|September 17, 2018
Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium EnhancementBrian P Halliday, A John Baksi, Ankur Gulati, et al.
JACC. Clinical Electrophysiology|February 19, 2021
Late-Gadolinium Enhancement Interface Area and Electrophysiological Simulations Predict Arrhythmic Events in Patients With Nonischemic Dilated CardiomyopathyGabriel Balaban, Brian P Halliday, Bradley Porter, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
European Journal of Heart Failure|June 18, 2025
Heart failure improvement, remission, and recovery: A European Journal of Heart Failure expert consensus documentJean-Sébastien Hulot, Jozine M Ter Maaten, Antoni Bayes-Genis, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|September 6, 2025
Visually assessed ischaemia on cardiac magnetic resonance, but not quantitative perfusion metrics, predicts symptomatic improvement in coronary artery bypassTamim Akbari, Lukas Mach, Daniel J Hammersley, et al.
Arxiv|June 5, 2025
In Silico Trials for Sex-Specific patient Inclusion Criteria in Cardiac Resynchronization Therapy: Advancing Precision in Heart Failure TreatmentShuang Qian, Devran Ugurlu, Elliot Fairweather, et al.
Journal of the American College of Cardiology|February 18, 2022
Myocardial Fibrosis Predicts Ventricular Arrhythmias and Sudden Death After Cardiac Electronic Device ImplantationFrancisco Leyva, Abbasin Zegard, Osita Okafor, et al.
ESC Heart Failure|March 8, 2022
Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathyBrian P Halliday, Ruth Owen, John Gregson, et al.
Open Heart|January 28, 2022
Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathyDaniel J Hammersley, Rachel J Buchan, Amrit S Lota, et al.
Journal of Cardiac Failure|January 14, 2022
Exposure to Elevated Nitrogen Dioxide Concentrations and Cardiac Remodeling in Patients With Dilated CardiomyopathyDaniela Fecht, Marc Chadeau-Hyam, Ruth Owen, et al.
Frontiers in Cardiovascular Medicine|October 24, 2022
The addition of genetic testing and cardiovascular magnetic resonance to routine clinical data for stratification of etiology in dilated cardiomyopathyRavi J Amin, Deborah Morris-Rosendahl, Mat Edwards, et al.
JACC. Cardiovascular Imaging|September 17, 2018
Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium EnhancementBrian P Halliday, A John Baksi, Ankur Gulati, et al.
JACC. Clinical Electrophysiology|February 19, 2021
Late-Gadolinium Enhancement Interface Area and Electrophysiological Simulations Predict Arrhythmic Events in Patients With Nonischemic Dilated CardiomyopathyGabriel Balaban, Brian P Halliday, Bradley Porter, et al.
Pageof 9